Back to Duquesne Family Office LLC Duquesne Family Office LLC

BBIOBBIO

2 quarters

Position history for Duquesne Family Office LLCDuquesne Family Office LLC's holdings in BridgeBio Pharma, Inc.

No. Duquesne Family Office exited its BBIO (BridgeBio Pharma) position in Q2 2025. Its Q1 2025 13F listed 438,050 shares worth $15.1M. Duquesne Family Office first reported BBIO in Q1 2025 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$15.1M

Total Shares Change

-438,050

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$43.18
0
2025-Q1
New
438,050
—
$15.1M0.5%$34.57
48

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used